A prospective ophthalmological study was done in 86 out of a total of
100 Swedes with established thalidomide embryopathy. Forty-six (54%) o
f all examined individuals had eye findings, which made the eve the se
cond most commonly affected organ in thalidomide embryopathy only surp
assed by upper limbs Forty-three patients (50%) had ocular motility de
fects, mostly incomitant strabismus. Facial palsy and abnormal lacrima
tion each occurred in 17 (20%) individuals. One patient had coloboma o
f the uvea and optic disc and another two had coloboma of the optic di
sc. Infrequent anomalies were microphthalmos, congenital glaucoma, lip
odermoid, and large refractive errors. The observed ocular motility de
fects, facial palsy and abnormal lacrimation occurred with early induc
ed defects in thalidomide embryopathy, but not with isolated late occu
rring anomalies. This suggests that thalidomide exerts its effects on
the development of these structures early in the teratogenic period, p
robably mainly during the fourth week of development.